CH495950A - Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen - Google Patents

Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen

Info

Publication number
CH495950A
CH495950A CH876668A CH876668A CH495950A CH 495950 A CH495950 A CH 495950A CH 876668 A CH876668 A CH 876668A CH 876668 A CH876668 A CH 876668A CH 495950 A CH495950 A CH 495950A
Authority
CH
Switzerland
Prior art keywords
tert
hydroxy
compounds
formula
optically active
Prior art date
Application number
CH876668A
Other languages
German (de)
English (en)
Inventor
Herbert Dr Koeppe
Zeile Karl Dr Prof
Albrecht Dr Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Priority to CH1168170A priority Critical patent/CH509973A/de
Priority to CH1168070A priority patent/CH510629A/de
Publication of CH495950A publication Critical patent/CH495950A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH876668A 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen CH495950A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH1168170A CH509973A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH1168070A CH510629A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0093025 DE1593782B2 (de) 1967-06-15 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
CH495950A true CH495950A (de) 1970-09-15

Family

ID=6986720

Family Applications (1)

Application Number Title Priority Date Filing Date
CH876668A CH495950A (de) 1967-06-15 1968-06-13 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen

Country Status (17)

Country Link
JP (2) JPS51100B1 (xx)
AT (8) AT289076B (xx)
BE (1) BE716647A (xx)
BG (6) BG15041A3 (xx)
CH (1) CH495950A (xx)
DE (1) DE1593782B2 (xx)
DK (1) DK127059B (xx)
ES (6) ES354823A1 (xx)
FI (1) FI48922C (xx)
FR (2) FR1583559A (xx)
GB (1) GB1187546A (xx)
IE (1) IE32373B1 (xx)
IL (1) IL30181A (xx)
MY (1) MY7300288A (xx)
NL (2) NL6808196A (xx)
SE (1) SE355571B (xx)
YU (7) YU35578B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
JPS57125772U (xx) * 1981-01-30 1982-08-05
DE3744371A1 (de) * 1987-12-29 1989-07-13 Jacobs Suchard Ag Verpackung fuer suesswaren
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (xx) * 1962-12-11

Also Published As

Publication number Publication date
AT289079B (de) 1971-04-13
DE1593782A1 (de) 1972-04-20
IE32373L (en) 1968-12-15
YU35578B (en) 1981-04-30
YU228974A (en) 1977-10-31
YU33778B (en) 1978-05-15
MY7300288A (en) 1973-12-31
YU228874A (en) 1977-10-31
BE716647A (xx) 1968-12-16
ES368395A1 (es) 1971-05-01
FI48922C (fi) 1975-02-10
FI48922B (xx) 1974-10-31
BG15039A3 (bg) 1975-12-15
DK127059B (da) 1973-09-17
YU33776B (en) 1978-05-15
ES354823A1 (es) 1970-02-16
YU229474A (en) 1977-10-31
ES368401A1 (es) 1971-05-01
YU229374A (en) 1980-09-25
ES368398A1 (es) 1971-05-01
AT289081B (de) 1971-04-13
NL6808196A (xx) 1968-12-16
NL136601C (xx)
AT289080B (de) 1971-04-13
FR8162M (xx) 1970-08-24
SE355571B (xx) 1973-04-30
AT289076B (de) 1971-04-13
JPS5112613B1 (xx) 1976-04-21
IE32373B1 (en) 1973-07-11
GB1187546A (en) 1970-04-08
BG15037A3 (bg) 1975-12-12
AT289067B (de) 1971-04-13
BG15041A3 (bg) 1975-10-22
YU33779B (en) 1978-05-15
JPS51100B1 (xx) 1976-01-05
ES368399A1 (es) 1971-05-01
YU229074A (en) 1977-10-31
YU33777B (en) 1978-05-15
FR1583559A (xx) 1969-11-14
YU229274A (en) 1977-10-31
YU229174A (en) 1977-10-31
YU33780B (en) 1978-05-15
BG15042A3 (bg) 1975-10-20
YU33775B (en) 1978-05-15
AT289077B (de) 1971-04-13
BG15038A3 (bg) 1975-06-10
AT289078B (de) 1971-04-13
ES368396A1 (es) 1971-05-01
DE1593782B2 (de) 1976-09-09
IL30181A0 (en) 1968-08-22
AT289082B (de) 1971-04-13
IL30181A (en) 1972-01-27
BG15040A3 (bg) 1975-10-25

Similar Documents

Publication Publication Date Title
DE2434911C2 (de) Phenyläthylamin-Derivate und pharmazeutische Zusammensetzungen
DE29724281U1 (de) 4-Phenylpiperidin-Verbindungen
DE1275069B (de) 1-(3', 5'-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoalkane und Verfahren zu ihrer Herstellung
DE1815808B2 (de) 1 -(Alkanoylamiitophenoxy)-3-alkylamino-2-propanole deren Herstellungsverfahren und pharmazeutische Zusammensetzungen auf deren Basis
CH495950A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
DE1793779A1 (de) Verfahren zur herstellung von (+)-2amino-1-butanol-(+)-hydrogentartrat
DE1468135C3 (xx)
DE1915230A1 (de) Hydroxyphenylalkylaminderivate und Verfahren zu deren Herstellung
CH510631A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
DE3410380A1 (de) S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen
CH509253A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
AT282595B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
CH509254A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
DE1182245B (de) Verfahren zur Herstellung eines uterospasmolytisch wirksamen linksdrehenden 1-(4'-Hy-droxyphenyl)-2-(1"-methyl-3"phenylpropylamino)-propanols
CH509255A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
CH509256A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
AT282593B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
CH509257A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.-butylaminopropanen und deren Salzen
AT282586B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
AT297681B (de) Verfahren zur Herstellung von neuen äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-butylaminopropanen, deren optisch aktiven Isomeren und Säureadditionssalzen
AT282592B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
CH510629A (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
DE1643266C3 (de) 1 Phenoxy 2 hydroxy 3 sek alkylamino propane, ein Verfahren zu ihrer Herstel lung und diese enthaltende Präparate
DE1593782C3 (de) 1-Nitrilophenoxy- 2- hydroxy -3- tertbutylaminopropane, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
AT289068B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen sowie von deren Säureadditionssalzen

Legal Events

Date Code Title Description
PL Patent ceased